TTrialPathMatch Me to Trials
← Back to trials
RecruitingGeneralized Anxiety Disorder (GAD)Anxiety Disorders

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

Eligible age

18–45 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) as an adjunct to cognitive behavioral therapy (CBT) in adults with generalized anxiety disorder (GAD). The study aims to evaluate whether cannabidiol-assisted CBT enhances emotion regulation via dorsomedial prefrontal cortex (dmPFC) activation and improves anxiety symptom outcomes compared to CBT with placebo.

Sponsor: Wayne State University

You may qualify if…

  • Right-handed
  • Age 18-45 years at enrollment
  • Able to consent to the study
  • Agree to adhere to lifestyle considerations throughout study duration
  • Generally medically and neurologically healthy, including no evidence of intellectual disability or serious cognitive impairment
  • Have a current generalized anxiety disorder (GAD) diagnosis according to the The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and/or total scores ≥ 8 on the 7-Item Generalized Anxiety Disorders Scale (GAD-7)

You may not qualify if…

  • Clinically significant medical or neurologic condition or neurocognitive dysfunction that would affect function and/or task performance and/or interfere with the study protocol
  • Any current (or within past 2 months) medical condition requiring medication that would interact with cannabidiol or interfere with the study protocol
  • Risk of harm to self or others that requires immediate intervention
  • Presence of contraindications, current or past allergic or adverse reaction, or known sensitivity to cannabinoid-like substances or components of EPIDIOLEX®
  • Positive drug screen or alcohol breathalyzer
  • Unwilling/unable to sign informed consent document
  • Currently pregnant (positive pregnancy test), planning pregnancy, or lactating (women),
  • Under 18 or over 45 years of age

Where it's recruiting

Michigan

Detroit

Source: ClinicalTrials.gov · NCT07123467 · last updated 2026-03-09